Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations.

Bangert M, Wright AK, Rylance J, Kelly MJ, Wright AD, Carlone GM, Sampson JS, Rajam G, Ades EW, Kadioglu A, Gordon SB.

Antimicrob Agents Chemother. 2013 Sep;57(9):4566-9. doi: 10.1128/AAC.00742-13. Epub 2013 Jul 1.

2.

Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae.

Phipps JC, Aronoff DM, Curtis JL, Goel D, O'Brien E, Mancuso P.

Infect Immun. 2010 Mar;78(3):1214-20. doi: 10.1128/IAI.00963-09. Epub 2009 Dec 14.

3.

Household air pollution causes dose-dependent inflammation and altered phagocytosis in human macrophages.

Rylance J, Fullerton DG, Scriven J, Aljurayyan AN, Mzinza D, Barrett S, Wright AK, Wootton DG, Glennie SJ, Baple K, Knott A, Mortimer K, Russell DG, Heyderman RS, Gordon SB.

Am J Respir Cell Mol Biol. 2015 May;52(5):584-93. doi: 10.1165/rcmb.2014-0188OC.

4.

Augmented Passive Immunotherapy with P4 Peptide Improves Phagocyte Activity in Severe Sepsis.

Morton B, Mitsi E, Pennington SH, Reiné J, Wright AD, Parker R, Welters ID, Blakey JD, Rajam G, Ades EW, Ferreira DM, Wang D, Kadioglu A, Gordon SB.

Shock. 2016 Dec;46(6):635-641.

PMID:
27488089
5.

Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.

Xu Q, Surendran N, Verhoeven D, Klapa J, Ochs M, Pichichero ME.

Vaccine. 2015 Feb 18;33(8):993-1000. doi: 10.1016/j.vaccine.2015.01.014. Epub 2015 Jan 15.

PMID:
25597944
6.

A 28-aa pneumococcal surface adhesin A-derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection.

Rajam G, Skinner J, Melnick N, Martinez J, Carlone GM, Sampson JS, Ades EW.

J Infect Dis. 2009 Apr 15;199(8):1233-8. doi: 10.1086/597425.

PMID:
19265478
7.

Dynamics of Increasing IFN-γ Exposure on Murine MH-S Cell-Line Alveolar Macrophage Phagocytosis of Streptococcus pneumoniae.

Mina MJ, Brown LA, Klugman KP.

J Interferon Cytokine Res. 2015 Jun;35(6):474-9. doi: 10.1089/jir.2014.0087. Epub 2015 Feb 25.

8.

Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.

Berenson CS, Kruzel RL, Eberhardt E, Sethi S.

J Infect Dis. 2013 Dec 15;208(12):2036-45. doi: 10.1093/infdis/jit400. Epub 2013 Aug 1.

9.

Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae.

Zhou H, Kobzik L.

Am J Respir Cell Mol Biol. 2007 Apr;36(4):460-5. Epub 2006 Nov 1.

10.

Thalidomide treatment modulates macrophage pro-inflammatory function and cytokine levels in Klebsiella pneumoniae B5055 induced pneumonia in BALB/c mice.

Kumar V, Harjai K, Chhibber S.

Int Immunopharmacol. 2010 Jul;10(7):777-83. doi: 10.1016/j.intimp.2010.04.008. Epub 2010 Apr 22.

PMID:
20399910
11.

Importance of bacterial replication and alveolar macrophage-independent clearance mechanisms during early lung infection with Streptococcus pneumoniae.

Camberlein E, Cohen JM, José R, Hyams CJ, Callard R, Chimalapati S, Yuste J, Edwards LA, Marshall H, van Rooijen N, Noursadeghi M, Brown JS.

Infect Immun. 2015 Mar;83(3):1181-9. doi: 10.1128/IAI.02788-14. Epub 2015 Jan 12.

12.

Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.

Wang J, Gigliotti F, Bhagwat SP, George TC, Wright TW.

PLoS Pathog. 2010 Aug 19;6(8):e1001058. doi: 10.1371/journal.ppat.1001058.

13.

The thiazolidinedione ciglitazone reduces bacterial outgrowth and early inflammation during Streptococcus pneumoniae pneumonia in mice.

Stegenga ME, Florquin S, de Vos AF, van der Poll T.

Crit Care Med. 2009 Feb;37(2):614-8. doi: 10.1097/CCM.0b013e31819599b6.

PMID:
19114898
14.

Silent cleanup of very early apoptotic cells by macrophages.

Kurosaka K, Takahashi M, Watanabe N, Kobayashi Y.

J Immunol. 2003 Nov 1;171(9):4672-9.

15.

Opsonic phagocytosis of Streptococcus pneumoniae by alveolar macrophages is not impaired in human immunodeficiency virus-infected Malawian adults.

Gordon SB, Molyneux ME, Boeree MJ, Kanyanda S, Chaponda M, Squire SB, Read RC.

J Infect Dis. 2001 Nov 15;184(10):1345-9. Epub 2001 Oct 15.

PMID:
11679928
16.

Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing.

Aberdein JD, Cole J, Bewley MA, Marriott HM, Dockrell DH.

Clin Exp Immunol. 2013 Nov;174(2):193-202. doi: 10.1111/cei.12170. Review.

17.

Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.

Delaval M, Boland S, Solhonne B, Nicola MA, Mornet S, Baeza-Squiban A, Sallenave JM, Garcia-Verdugo I.

Part Fibre Toxicol. 2015 Jan 21;12:1. doi: 10.1186/s12989-014-0078-9.

18.

Nasopharyngeal colonization and invasive disease are enhanced by the cell wall hydrolases LytB and LytC of Streptococcus pneumoniae.

Ramos-Sevillano E, Moscoso M, García P, García E, Yuste J.

PLoS One. 2011;6(8):e23626. doi: 10.1371/journal.pone.0023626. Epub 2011 Aug 23.

19.

Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia.

Hsu A, Aronoff DM, Phipps J, Goel D, Mancuso P.

Clin Exp Immunol. 2007 Nov;150(2):332-9. Epub 2007 Sep 5.

20.

5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae.

Mancuso P, Standiford TJ, Marshall T, Peters-Golden M.

Infect Immun. 1998 Nov;66(11):5140-6.

Supplemental Content

Support Center